9:32am ET
Health and Healthcare
6 Biotech and Pharma Stocks Analysts Want You to Buy Now
Here are six biotech and pharma stocks that analysts are telling their firm's clients to buy now for solid upside opportunities ahead.
Companies
/Healthcare
Pfizer Inc
$28.67
▲ $0.26 (+0.92%) today
Markets closed · 2:14am ET
PFE Coverage
Page 59
9:15am ET
Health and Healthcare
Short Sellers Increase Bets in Major Pharma
The January 29 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest increased.
6:15am ET
Investing
The 6 Most Shorted NYSE Stocks: Short Sellers Pile on Alcoa, Freeport-McMoRan Again
Among the six most heavily shorted stocks traded on the New York Stock Exchange, short sellers continued to pile on Alcoa and Freeport-McMoRan between the January 15 and January 29 settlement dates.
11:35am ET
Health and Healthcare
Why Merrill Lynch Sees Big Upside in Pfizer (and Even More With Allergan)
Merrill Lynch has decided to add Pfizer as its new top pick for 2016. The firm reiterated a Buy rating with a $39 price target.
8:55am ET
Investing
Top Analyst Upgrades and Downgrades: Apple, Freeport-McMoRan, Kinross Gold, Pfizer, Plains All American, Salesforce, Tesla, Yelp and More
The top analyst upgrades, downgrades and initiations seen on Tuesday include Apple, Freeport-McMoRan, Kinross Gold, Pfizer, Plains All American, Salesforce,com, Tesla and Yelp.
8:25am ET
Health and Healthcare
4 Big Dividend Pharmaceutical Stocks to Buy That Are Very Cheap Now
If you ever want to look for value in a sector in the stock market, then when you see Congress calling in some of the top companies to scold them for political…
10:15am ET
Health and Healthcare
How Analysts View Pfizer and Merck After Earnings
After Pfizer and Merck released their most recent earnings reports last week, analysts weighed in on both of these pharmaceutical giants.
10:45am ET
Investing
Merrill Lynch Has 4 Very Oversold Blue Chip Dividend Stocks to Buy Now
Needless to say, the stock market can be a very cruel mistress. So what are patient long-term investors to do?
8:05am ET
Health and Healthcare
Investors OK With Pfizer Earnings, Not OK With Guidance
Pfizer reported better-than-expected fourth-quarter and full-year 2015 results before markets opened Tuesday morning.
Paul Ausick 1:25pm ET
Health and Healthcare
What to Expect From Pfizer Earnings
Pfizer is scheduled to report its fourth-quarter financial results before the markets open on Tuesday.
Chris Lange 10:10am ET
Investing
Top 3 Dow Earnings for the Coming Week
24/7 Wall St. has put together a preview of the three Dow Jones Industrial Average companies that are reporting their quarterly results this week.
10:50am ET
Investing
5 Dow Stocks Getting Slammed in 2016 Have Not Even Reported Earnings Yet
Some of the Dow stocks that are down in 2016 haven't even reported earnings. This is the market bracing for bad news, but one cannot wonder if that means that the earnings…
9:05am ET
Investing
4 Out-Of-Favor Large-Cap Blue-Chip Dividend Stocks to Buy Now
Needless to say, the stock market can be a very cruel mistress. Companies can report great numbers, but if the guidance is light? Look out!
8:40am ET
Health and Healthcare
Short Sellers Become More Selective on Major Pharma
The January 15 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.
6:15am ET
Investing
The 6 Most Shorted NYSE Stocks: Short Sellers Pile on Alcoa, Freeport-McMoRan
Perhaps not surprisingly, in early January, short interest was on the rise for most of the top six most heavily shorted stocks traded on the New York Stock Exchange.